REVIVA PHARMACEUTICALS HOLDI (RVPH) Stock Balance Sheet
USA - NASDAQ:RVPH - US76152G1004 - Common Stock
0.5792 USD
+0.02 (+3.28%)
0.5711 USD
-0.01 (-1.4%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 10.36M | 13.48M | 23.37M | 18.52M | 29.69M | |||
| Cash Equivalents | null | null | null | null | null | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | null | null | null | |||
| Receivables | null | null | null | null | null | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 451.40K | 1.21M | 333.00K | 404.00K | 1.72M | |||
| Total Current Assets | 10.82M | 14.68M | 23.70M | 18.92M | 31.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | null | null | null | null | null | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | 819.70K | 820.00K | null | null | null | |||
| Total Non-Current Assets | 819.80K | 820.00K | 0 | 0 | 0 | |||
| TOTAL ASSETS | 11.63M | 15.50M | 23.70M | 18.92M | 31.40M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 113.30K | 458.00K | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | null | null | null | null | null | |||
| Accrued Expenses | 7.00M | 7.86M | 13.33M | 6.44M | 1.83M | |||
| Accounts Payable | 4.97M | 6.28M | 3.85M | 3.52M | 510.00K | |||
| Other Current Liabilities | null | null | null | null | null | |||
| Total Current Liabilities | 12.08M | 14.60M | 17.18M | 9.96M | 2.35M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 16.70K | 89.00K | 807.00K | 567.00K | 373.00K | |||
| Total Non-Current Liabilities | 16.70K | 89.00K | 807.00K | 567.00K | 373.00K | |||
| TOTAL LIABILITIES | 12.09M | 14.69M | 17.98M | 10.53M | 2.72M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -176.76M | -164.27M | -134.35M | -95.09M | -66.83M | |||
| Additional Paid In Capital | 176.29M | 165.08M | 140.07M | 103.49M | 95.52M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 6.80K | 5.00K | 3.00K | 2.00K | 1.00K | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | null | null | null | null | null | |||
| Shares Outstanding | 68.00M | 46.58M | 27.92M | 20.45M | 14.43M | |||
| Tangible Book Value per Share | -0.0068 | 0.0175 | 0.2048 | 0.4105 | 1.9875 | |||
| Total Shareholders' Equity | -459.20K | 813.00K | 5.72M | 8.39M | 28.69M | |||
| TOTAL LIABILITIES AND EQUITY | 11.63M | 15.50M | 23.70M | 18.92M | 31.40M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 0.90 | 1.01 | 1.38 | 1.90 | 13.39 | |||
| Return On Assets (ROA) | -233.02% | -192.99% | -165.66% | -149.34% | -27.14% | |||
| Return On Equity (ROE) | N/A | -3680.05% | -686.50% | -336.69% | -29.71% | |||
All data in USD , ROIC based on taxRate of 0.21